Facile fabrication of redox nanoparticles loaded with exosomal-miRNAs and resveratrol as glycation inhibitor in alleviating the progression and development of diabetic cataract DOI
Xia Chen, Xi Qian,

Fei Sun

et al.

Naunyn-Schmiedeberg s Archives of Pharmacology, Journal Year: 2024, Volume and Issue: unknown

Published: Oct. 24, 2024

Language: Английский

Synergistic Osteogenic and Antiapoptotic Framework Nucleic Acid Complexes Prevent Diabetic Osteoporosis DOI
Long Bai,

Maogeng Feng,

Qiuwen Zhang

et al.

Advanced Functional Materials, Journal Year: 2024, Volume and Issue: 34(28)

Published: March 12, 2024

Abstract Diabetes mellitus (DM) is characterized by elevated blood glucose and advanced glycation end product (AGEs) levels. Increased AGEs in bone tissue inhibit osteogenic differentiation marrow mesenchymal stem cells (BMSCs), leading to loss osteoporosis diabetic patients. Enhancing the capacity of BMSCs presence abundant can improve health prevent DM The flavonoid, Quercetin, has anti‐inflammatory, antibacterial, antitumor properties; however, it insoluble water thus not easily absorbed body. Nanodrug delivery systems such as tetrahedral framework nucleic acids (tFNAs) exhibit excellent biocompatibility, efficient cell uptake, drug piggybacking. In present study, tFNAs with quercetin complexed form a novel nanodrug (tFNAs/Que) that combined features both components. tFNAs/Que promote an vitro AGEs‐rich environment, maintain mass, mice vivo. mechanism against may be related JNK signaling pathway. conclusion, shown dual regulatory role promoting inhibiting apoptosis. Such feature promising for prevention treatment osteoporosis.

Language: Английский

Citations

31

Aptamer-Based Smart Targeting and Spatial Trigger–Response Drug-Delivery Systems for Anticancer Therapy DOI Creative Commons

Dongsik Park,

Su Jin Lee, Jee-Woong Park

et al.

Biomedicines, Journal Year: 2024, Volume and Issue: 12(1), P. 187 - 187

Published: Jan. 15, 2024

In recent years, the field of drug delivery has witnessed remarkable progress, driven by quest for more effective and precise therapeutic interventions. Among myriad strategies employed, integration aptamers as targeting moieties stimuli-responsive systems emerged a promising avenue, particularly in context anticancer therapy. This review explores cutting-edge advancements targeted drug-delivery systems, focusing on platforms enhanced spatial aptamer-based we delve into versatile applications aptamers, examining their conjugation with gold, silica, carbon materials. The synergistic interplay between these materials is discussed, emphasizing potential achieving delivery. Additionally, explore an emphasis Tumor microenvironment-responsive nanoparticles are elucidated, capacity to exploit dynamic conditions within cancerous tissues controlled release detailed. External strategies, including ultrasound-mediated, photo-responsive, magnetic-guided examined role effects. integrates diverse approaches precision medicine, showcasing revolutionize

Language: Английский

Citations

18

Receptor-ligand interactions for optimized endocytosis in targeted therapies DOI Creative Commons

Yejin Sung,

Young‐Jin Choi, Eun Sun Kim

et al.

Journal of Controlled Release, Journal Year: 2025, Volume and Issue: 380, P. 524 - 538

Published: Feb. 12, 2025

Receptor-mediated endocytosis plays a crucial role in the success of numerous therapies and remains central to advancing drug development. This process begins with ligand binding specific receptors, triggering internalization intracellular trafficking receptor-ligand complexes. These complexes are subsequently directed into distinct routes, either toward lysosomal degradation or recycling cell surface, implications for therapeutic outcomes. review examines interactions as key modulators endocytosis, emphasizing their shaping design efficacy. Advances selecting pairs engineering ligands optimized properties have enabled precise control over internalization, endosomal sorting, trafficking, providing tailored solutions diverse applications. Leveraging these insights, strategies such RNA-based therapies, antibody-drug conjugates (ADCs), targeted protein (TPD) platforms been refined selectively avoid promote degradation, thereby enhancing By bridging fundamental mechanisms receptor-mediated innovative approaches, this offers framework precision medicine.

Language: Английский

Citations

3

Current Understanding and Translational Prospects of Tetrahedral Framework Nucleic Acids DOI Creative Commons
Junjie Gu,

Jiale Liang,

Taoran Tian

et al.

JACS Au, Journal Year: 2025, Volume and Issue: 5(2), P. 486 - 520

Published: Feb. 10, 2025

Tetrahedral framework nucleic acids (tFNAs) represent a promising advancement in acid nanotechnology due to their unique structural properties, high biocompatibility, and multifaceted biomedical applications. Constructed through one-pot annealing method, four single-stranded DNAs self-assemble into stable, three-dimensional tetrahedral nanostructures with enhanced mechanical robustness physiological stability, resisting enzymatic degradation. Their ability permeate mammalian cells without transfection agents, coupled modifiable surfaces, positions tFNAs as versatile carriers for drug gene delivery systems. The tFNA-based platforms exhibit superior therapeutic efficacy, including antioxidative anti-inflammatory effects, alongside efficient cellular uptake tissue penetration. These features underpin role precision medicine, enabling targeted of diverse agents such synthetic compounds, peptides, acids. Additionally, demonstrate significant potential regenerative immune modulation, antibacterial strategies, oncology. By addressing challenges translational integration, stand poised accelerate the development research clinical applications, fostering novel therapies enhancing outcomes across wide spectrum diseases. This Perspective thoroughly details attributes applications critically evaluates tFNAs' potential, outlining inherent implementation exploring solutions these obstacles.

Language: Английский

Citations

2

Advancements in Aptamer‐Driven DNA Nanostructures for Precision Drug Delivery DOI Creative Commons
Moein Safarkhani, Sepideh Ahmadi,

Hossein Ipakchi

et al.

Advanced Science, Journal Year: 2024, Volume and Issue: 11(26)

Published: May 7, 2024

Abstract DNA nanostructures exhibit versatile geometries and possess sophisticated capabilities not found in other nanomaterials. They serve as customizable nanoplatforms for orchestrating the spatial arrangement of molecular components, such biomolecules, antibodies, or synthetic This is achieved by incorporating oligonucleotides into design nanostructure. In realm drug delivery to cancer cells, there a growing interest active targeting assays enhance efficacy selectivity. The approach involves “key‐lock” mechanism where carrier, through its ligand, recognizes specific receptors on tumor facilitating release drugs. Various nanostructures, including origami, Tetrahedral, nanoflower, cruciform, nanostar, nanocentipede, nanococklebur, can traverse lipid layer cell membrane, allowing cargo nucleus. Aptamers, easily formed vitro, are recognized their targeted due high selectivity targets low immunogenicity. review provides comprehensive overview recent advancements formation modification aptamer‐modified within systems.

Language: Английский

Citations

15

Ratiometric Fluorescence Aptasensor of Allergen Protein Based on Multivalent Aptamer-Encoded DNA Flowers as Fluorescence Resonance Energy Transfer Platform DOI
Shuo Qi, Xiaoze Dong, Eslam M. Hamed

et al.

Analytical Chemistry, Journal Year: 2024, Volume and Issue: 96(18), P. 6947 - 6957

Published: April 24, 2024

Life-threatening allergic reactions to food allergens, particularly peanut protein Ara h1, are a growing public health concern affecting millions of people worldwide. Thus, accurate and rapid detection is necessary for allergen labeling dietary guidance ultimately preventing incidents. Herein, we present novel ratiometric fluorescence aptasensor based on multivalent aptamer-encoded DNA flowers (Mul-DNFs) the high-stability sensitive h1. The flower-shaped Mul-DNFs were spontaneously packaged using ultralong polymeric amplicons driven by rolling circle amplification reaction, which contains large number h1 specific recognition units has excellent binding properties. Furthermore, dual-color fluorescence-labeled probes developed hybridizing them with Cy3- Cy5-labeled complementary (cDNA) serve as platform resonance energy transfer. Benefiting from combined merits extraordinary synergistic ability Mul-DNFs, specificity aptamer, sensitivity sensor avoid exogenous interference. showed linearity (0.05–2000 ng mL–1) limit 0.02 mL–1. Additionally, was utilized quantifying presence in milk, infant milk powder, cookies, bread, chocolate recoveries 95.7–106.3%. proposed expected be prospective universal rapid, sensitive, determination environmental hazards.

Language: Английский

Citations

14

Cytotoxic effects of NIR responsive chitosan-polymersome layer coated melatonin-upconversion nanoparticles on HGC27 and AGS gastric cancer cells: Role of the ROS/PI3K/Akt/mTOR signaling pathway DOI
Zhiyuan Fan,

Yuheng Shao,

Xiao Jiang

et al.

International Journal of Biological Macromolecules, Journal Year: 2024, Volume and Issue: 278, P. 134187 - 134187

Published: Aug. 3, 2024

Language: Английский

Citations

9

Designing Multivalent Aptamers: Recent Advancements in Diagnostic and Therapeutic Approaches for Cancer Treatment DOI
Zahra Moradi, Khalil Abnous, Seyed Mohammad Taghdisi

et al.

Journal of Drug Delivery Science and Technology, Journal Year: 2025, Volume and Issue: unknown, P. 106614 - 106614

Published: Jan. 1, 2025

Language: Английский

Citations

1

Emerging Strategies to Overcome Chemoresistance: Structural Insights and Therapeutic Targeting of Multidrug Resistance-Linked ATP-Binding Cassette Transporters DOI Creative Commons
Raghavendra Sashi Krishna Nagampalli, Gangadhar P. Vadla, Eswar Kumar Nadendla

et al.

International Journal of Translational Medicine, Journal Year: 2025, Volume and Issue: 5(1), P. 6 - 6

Published: Jan. 10, 2025

The ATP-binding cassette (ABC) transporter superfamily, one of the largest membrane protein families, plays a crucial role in multidrug resistance (MDR) cancer by mediating efflux various chemotherapeutic agents, thereby lowering their intracellular concentrations and diminishing therapeutic effectiveness. Beyond drug efflux, these transporters are also involved vital biological processes, such as signal transduction cancer. Over past few decades, extensive structural functional research has provided valuable insights into ABC transporters’ broad substrate specificity transport mechanisms, leading to promising strategies for overcoming MDR. This review will provide understanding interactions between inhibitors develop novel therapeutics. Additionally, we focus on methods irradiation-based immune therapies, thermal nanomedicine, CRISPR-Cas, natural therapies that can genetically modify reduce expression or reverse ability. Knowledge gained from approaches then be translated development new therapeutics combat chemotherapy resistance.

Language: Английский

Citations

1

Targeted delivery of CEBPA-saRNA for the treatment of pancreatic ductal adenocarcinoma by transferrin receptor aptamer decorated tetrahedral framework nucleic acid DOI Creative Commons

Li Wang,

Qunyan Yao,

Xuerui Guo

et al.

Journal of Nanobiotechnology, Journal Year: 2024, Volume and Issue: 22(1)

Published: July 4, 2024

Abstract Pancreatic cancer, predominantly pancreatic ductal adenocarcinoma (PDAC), remains a highly lethal malignancy with limited therapeutic options and dismal prognosis. By targeting the underlying molecular abnormalities responsible for PDAC development progression, gene therapy offers promising strategy to overcome challenges posed by conventional radiotherapy chemotherapy. This study sought explore potential of small activating RNAs (saRNAs) specifically CCAAT/enhancer-binding protein alpha ( CEBPA ) in PDAC. To associated saRNA delivery, tetrahedral framework nucleic acids (tFNAs) were rationally engineered as nanocarriers. These tFNAs further functionalized truncated transferrin receptor aptamer (tTR14) enhance specificity cells. The constructed tFNA-based formulation demonstrated exceptional stability, efficient release ability, substantial cellular uptake, biocompatibility, nontoxicity. In vitro experiments revealed successful intracellular delivery -saRNA utilizing tTR14-decorated tFNA nanocarriers, resulting significant activation tumor suppressor genes, namely, its downstream effector P21 , leading notable inhibition cell proliferation. Moreover, mouse model PDAC, tFNA-mediated effectively upregulated expression consequently suppressing growth. compelling findings highlight utility delivered via designed nanocarrier induce genes an innovative approach

Language: Английский

Citations

6